Status:
COMPLETED
Benefits Study of Respiratory-gated Positron Emission Tomography Acquisitions of the Liver
Lead Sponsor:
Centre Hospitalier Universitaire, Amiens
Conditions:
Liver Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Fluorodeoxyglucose (FDG) positron emission tomography (PET) is now widely used for cancer imaging purpose, notably for preoperative work-up. It aims at visualizing organs metabolism. In case of cancer...
Detailed Description
Introduction: 18-fluoro-2-deoxyglucose (18F-FDG) positron emission tomography/computed tomography (PET/CT) became a major imaging modality for management of patients with suspected hepatic cancer not...
Eligibility Criteria
Inclusion
- patient planed to undergo any liver surgical intervention
- age : over 18
- patients gave their written informed consent
Exclusion
- pregnancy
- liver surgical intervention cancel upon surgical or medical decision
Key Trial Info
Start Date :
April 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2010
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT01219985
Start Date
April 1 2008
End Date
June 1 2010
Last Update
May 27 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
centre hospitalier universitaire d'Amiens
Amiens, Picardy, France, 80054